Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies
- PMID: 22492510
- PMCID: PMC3401466
- DOI: 10.1093/nar/gks281
Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies
Abstract
Numerous examples exist of how disrupting the actions of physiological regulators of blood cell development yields hematologic malignancies. The master regulator of hematopoietic stem/progenitor cells GATA-2 was cloned almost 20 years ago, and elegant genetic analyses demonstrated its essential function to promote hematopoiesis. While certain GATA-2 target genes are implicated in leukemogenesis, only recently have definitive insights emerged linking GATA-2 to human hematologic pathophysiologies. These pathophysiologies include myelodysplastic syndrome, acute myeloid leukemia and an immunodeficiency syndrome with complex phenotypes including leukemia. As GATA-2 has a pivotal role in the etiology of human cancer, it is instructive to consider mechanisms underlying normal GATA factor function/regulation and how dissecting such mechanisms may reveal unique opportunities for thwarting GATA-2-dependent processes in a therapeutic context. This article highlights GATA factor mechanistic principles, with a heavy emphasis on GATA-1 and GATA-2 functions in the hematopoietic system, and new links between GATA-2 dysregulation and human pathophysiologies.
Figures
Similar articles
-
The role of the GATA2 transcription factor in normal and malignant hematopoiesis.Crit Rev Oncol Hematol. 2012 Apr;82(1):1-17. doi: 10.1016/j.critrevonc.2011.04.007. Epub 2011 May 24. Crit Rev Oncol Hematol. 2012. PMID: 21605981 Review.
-
[GATA factor-related hematopoietic neoplasms].Rinsho Ketsueki. 2024;65(9):902-910. doi: 10.11406/rinketsu.65.902. Rinsho Ketsueki. 2024. PMID: 39358289 Review. Japanese.
-
GATA-related hematologic disorders.Exp Hematol. 2016 Aug;44(8):696-705. doi: 10.1016/j.exphem.2016.05.010. Epub 2016 May 25. Exp Hematol. 2016. PMID: 27235756 Review.
-
The role of GATA family transcriptional factors in haematological malignancies: A review.Medicine (Baltimore). 2024 Mar 22;103(12):e37487. doi: 10.1097/MD.0000000000037487. Medicine (Baltimore). 2024. Retraction in: Medicine (Baltimore). 2024 May 3;103(18):e38232. doi: 10.1097/MD.0000000000038232 PMID: 38518015 Free PMC article. Retracted. Review.
-
The GATA factor revolution in hematology.Blood. 2017 Apr 13;129(15):2092-2102. doi: 10.1182/blood-2016-09-687871. Epub 2017 Feb 8. Blood. 2017. PMID: 28179282 Free PMC article. Review.
Cited by
-
The biochemistry of hematopoietic stem cell development.Biochim Biophys Acta. 2013 Feb;1830(2):2395-403. doi: 10.1016/j.bbagen.2012.10.004. Epub 2012 Oct 12. Biochim Biophys Acta. 2013. PMID: 23069720 Free PMC article. Review.
-
Erythro-megakaryocytic transcription factors associated with hereditary anemia.Blood. 2014 May 15;123(20):3080-8. doi: 10.1182/blood-2014-01-453167. Epub 2014 Mar 20. Blood. 2014. PMID: 24652993 Free PMC article. Review.
-
GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.Blood. 2014 Feb 6;123(6):809-21. doi: 10.1182/blood-2013-07-515528. Epub 2013 Nov 13. Blood. 2014. PMID: 24227816 Free PMC article.
-
Loss of c-Kit and bone marrow failure upon conditional removal of the GATA-2 C-terminal zinc finger domain in adult mice.Eur J Haematol. 2016 Sep;97(3):261-70. doi: 10.1111/ejh.12719. Epub 2016 Jan 14. Eur J Haematol. 2016. PMID: 26660446 Free PMC article.
-
In pursuit of design principles of regulatory sequences.Nat Rev Genet. 2014 Jul;15(7):453-68. doi: 10.1038/nrg3684. Epub 2014 Jun 10. Nat Rev Genet. 2014. PMID: 24913666 Review.
References
-
- Yamamoto M, Ko LJ, Leonard MW, Beug H, Orkin SH, Engel JD. Activity and tissue-specific expression of the transcription factor NF-E1 multigene family. Genes Dev. 1990;4:1650–1662. - PubMed
-
- Dorfman DM, Wilson DB, Bruns GA, Orkin SH. Human transcription factor GATA-2. Evidence for regulation of preproendothelin-1 gene expression in endothelial cells. J. Biol. Chem. 1992;267:1279–1285. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials